Clarivate Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	2.4yrs
Gemiddelde ambtstermijn bestuur	3.2yrs

Recente managementupdates

Recent updates

CEO

Clarivate heeft geen CEO, of we hebben geen gegevens over hen.

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Jonathan Collins	Executive VP & CFO	2.9yrs	US$4.74m	0.10% € 4.4m
Gordon Samson	President of Intellectual Property	no data	US$3.85m	0.10% € 4.5m
Bar Veinstein	President of Academia & Government	1.6yrs	US$9.29m	0.018% € 797.6k
Henry Levy	President of Life Sciences & Healthcare	1.5yrs	US$5.24m	0.081% € 3.6m
Michael Easton	Senior VP of Finance & Chief Accounting Officer	2.4yrs	geen gegevens	0.0098% € 434.8k
William Graff	Executive VP & Chief Information Officer	2.7yrs	geen gegevens	0.059% € 2.6m
Mark Donohue	Head of Investor Relations	no data	geen gegevens	geen gegevens
Melanie Margolin	Chief Legal Officer & Secretary	1.2yrs	geen gegevens	0.093% € 4.1m
Tabita Andersson	Senior Vice President of Communications & Brand	no data	geen gegevens	geen gegevens
Richard Finch	Global Head of Life Sciences Consulting Services	5.3yrs	geen gegevens	geen gegevens
Melanie Fitzpatrick	Executive of Digital First Transformation	no data	geen gegevens	geen gegevens

2.4yrs

Gemiddelde duur

51yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 16A wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.4 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Anthony Munk	Independent Director	5.5yrs	geen gegevens	geen gegevens
Michael Angelakis	Independent Director	2.9yrs	US$250.00k	0.0045% € 198.7k
Jerre Stead	Chairman Emeritus	2.1yrs	US$4.79m	geen gegevens
Andrew Snyder	Independent Non-Executive Chairman of the Board	2.9yrs	US$370.00k	0.043% € 1.9m
Richard Roedel	Independent Director	4.5yrs	US$295.11k	0.020% € 894.9k
Usama Cortas	Independent Director	4.1yrs	geen gegevens	geen gegevens
Valeria Alberola	Independent Director	3.5yrs	US$250.00k	0.0080% € 354.3k
Jane Bomba	Independent Director	4.5yrs	US$280.00k	0.022% € 965.6k
Wendell Pritchett	Independent Director	2.3yrs	US$270.00k	0.0035% € 155.2k
Adam Levyn	Independent Director	4.1yrs	geen gegevens	geen gegevens
Saurabh Saha	Independent Director	1.5yrs	US$221.04k	0% € 0
Suzanne Heywood	Independent Director	less than a year	geen gegevens	geen gegevens

3.2yrs

Gemiddelde duur

59yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 16A wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.2 jaar).

Clarivate Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Clarivate plc Appoints Melanie Margolin as Chief Administrative and Legal Officer

Clarivate plc Announces Directorate Changes

Clarivate plc Announces Board and Committee Changes

Clarivate Plc, Annual General Meeting, May 07, 2024

Clarivate Plc, Annual General Meeting, Jul 27, 2023

Clarivate Plc Elects Saurabh Saha as Director

Recent updates

Silverchair Science + Communications, Inc. signed a definitive agreement to acquire ScholarOne, Inc. from Clarivate Plc (NYSE:CLVT).

Clarivate Plc to Report Q3, 2024 Results on Nov 06, 2024

Clarivate Launches Generative AI-Powered Web of Science Research Assistant

Clarivate plc Appoints Melanie Margolin as Chief Administrative and Legal Officer

New minor risk - Shareholder dilution

Second quarter 2024 earnings released: US$0.46 loss per share (vs US$0.21 loss in 2Q 2023)

Clarivate plc Announces Directorate Changes

Clarivate plc Announces Board and Committee Changes

Clarivate Plc (NYSE:CLVT) acquired Rowan TELS Corp.

Clarivate Plc to Report Q2, 2024 Results on Aug 06, 2024

Clarivate Plc Launches IP Collaboration Hub

Clarivate Plc Reaffirms Earnings Guidance for the Fiscal Year 2024

First quarter 2024 earnings released: US$0.14 loss per share (vs US$0.037 profit in 1Q 2023)

Clarivate Plc Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory Success

Clarivate Plc to Report Q1, 2024 Results on May 08, 2024

Astorg Reportedly Considers Sale of Anaqua

Clarivate Plc, Annual General Meeting, May 07, 2024

Clarivate plc Provides Earnings Guidance for the Fiscal Year 2024

Full year 2023 earnings released: US$1.47 loss per share (vs US$5.97 loss in FY 2022)

Clarivate Plc to Report Q4, 2023 Results on Feb 27, 2024

Investor sentiment improves as stock rises 16%

Clarivate plc Announces Launch of New Special Report Series, Electrophysiology Mapping and Ablation Devices Market Insights

Investor sentiment improves as stock rises 17%

Third quarter 2023 earnings released: US$0.01 loss per share (vs US$6.58 loss in 3Q 2022)

Clarivate plc Provides Revenue Guidance for the Full Year 2023

Impactive Capital Engages in Discussions with Clarivate Plc

Clarivate Plc to Report Q3, 2023 Results on Nov 07, 2023

New minor risk - Profitability

New major risk - Share price stability

Clarivate Plc (NYSE:CLVT) acquired Alethea.

Clarivate Plc Establishes Academia & Government Innovation Incubator

New minor risk - Share price stability

Forecast breakeven date pushed back to 2024

Clarivate plc Updates Earnings Guidance for the Year 2023

Second quarter 2023 earnings released: US$0.21 loss per share (vs US$0.065 profit in 2Q 2022)

Clarivate Plc to Report Q2, 2023 Results on Aug 03, 2023

Clarivate Plc, Annual General Meeting, Jul 27, 2023

Clarivate Plc Elects Saurabh Saha as Director

Forecast breakeven date moved forward to 2023

Clarivate plc Provides Earnings Guidance for the Year 2023

First quarter 2023 earnings released: EPS: US$0.037 (vs US$0.074 in 1Q 2022)

No longer forecast to breakeven

Clarivate Plc to Report Q4, 2022 Results on Mar 01, 2023

Clarivate plc Announces Board Changes

Chief Product Officer recently sold €1.0m worth of stock

Forecast breakeven date pushed back to 2024

Third quarter 2022 earnings released: US$6.58 loss per share (vs US$0.009 profit in 3Q 2021)

Forecast to breakeven in 2022

Clarivate Plc Revises Earnings Guidance for the Full Year 2022

Clarivate Plc and OCLC Settle Lawsuit

Clarivate Plc to Report Q3, 2022 Results on Nov 08, 2022

Clarivate Plc Announces Board Changes

Second quarter 2022 earnings released: EPS: US$0.065 (vs US$0.21 loss in 2Q 2021)

Clarivate Plc Revises Earnings Guidance for Full Year 2022

Clarivate plc Elects Dr. Wendell E. Pritchett as New Member of Board

Forecast breakeven date pushed back to 2023

Clarivate Announces Jonathan Gear as Member of the Board of Directors

Clarivate Plc to Report Q2, 2022 Results on Aug 09, 2022

Forecast breakeven date moved forward to 2022

Chief Product Officer recently sold €660k worth of stock

First quarter 2022 earnings released: EPS: US$0.074 (vs US$0.093 loss in 1Q 2021)

Clarivate plc Provides Earnings Guidance for 2022

Clarivate Plc Announces a New Report, Traversing the Evolving Trademark Landscape: Discover Trends, Challenges and Opportunities Through the Lens of IP Intelligence

Clarivate Plc to Report Q1, 2022 Results on May 09, 2022

Clarivate Plc Announces Nicholas Macksey and Charles J. Neral Not Standing for Reelection as Directors

Gross Law Firm Notifies Shareholders of Clarivate plc of Class Action Lawsuit and Lead Plaintiff Deadline of March 25, 2022

Clarivate Plc to Report Q4, 2021 Results on Mar 10, 2022

Clarivate Plc Provides in-Depth Analyses of Long Covid Studies, Potentially the Next Public Health Crisis

Clarivate Plc (NYSE:CLVT) announces an Equity Buyback for $1,000 million worth of its shares.